Search clinical trials for: Eribulin and Tucidinostat
Total 271992 results
-
Henan Cancer HospitalRecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
Chipscreen Biosciences, Ltd.RecruitingNon Small Cell Lung CancerChina
-
Great Novel Therapeutics Biotech & Medicals CorporationRecruitingRelapsed or Refractory Peripheral T-cell LymphomaTaiwan
-
Beijing 302 HospitalRecruiting
-
oubaiUnknownDiffuse Large B-cell LymphomaChina
-
Zhejiang Cancer HospitalNot yet recruiting
-
Sun Yat-sen UniversityRecruitingTriple Negative Breast CancerChina
-
Eisai LimitedCompleted
-
Spexis AGTerminatedMetastatic Breast Cancer | Locally Recurrent Breast CancerSpain, Belgium, United States, United Kingdom, Korea, Republic of, Taiwan, Italy, Russian Federation, Czechia, France, Brazil, Argentina, Ukraine
-
Great Novel Therapeutics Biotech & Medicals CorporationRecruiting
-
Eisai LimitedCompletedAdvanced Solid TumorFrance
-
H. Lee Moffitt Cancer Center and Research InstituteEisai Inc.CompletedBreast CancerUnited States
-
Eisai GmbHCompletedLocally Advanced or Metastatic Breast CancerGermany
-
Seoul National University HospitalRecruitingAdvanced Breast CancerKorea, Republic of
-
Translational Research Center for Medical Innovation...Kyoto Breast Cancer Research NetworkCompleted
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingTriple Negative Breast CancerChina
-
National Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Massachusetts General HospitalEisai Inc.Active, not recruitingAngiosarcoma | Epithelioid HemangioendotheliomaUnited States
-
Institut Cancerologie de l'OuestCompleted
-
Eisai Korea Inc.CompletedBreast Cancer | Breast NeoplasmsKorea, Republic of
-
Eisai Inc.Approved for marketingMetastatic Breast CancerCanada, Belgium, France
-
MedSIRMenarini GroupRecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast CancerSpain
-
Fudan UniversityNot yet recruiting
-
Eisai Inc.Completed
-
Eisai Co., Ltd.Completed
-
Eisai Inc.Completed
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia and other collaboratorsCompletedMetastatic Breast CancerSpain, United Kingdom
-
Eisai Inc.Completed
-
Shengjing HospitalNot yet recruitingTriple Negative Breast CancerChina
-
Hunan Cancer HospitalCompletedMetastatic Breast CancerChina
-
Oncologia Medica dell'Ospedale FatebenefratelliMario Negri Institute for Pharmacological ResearchCompletedMetastatic Breast Cancer | Toxicity | Neurotoxicity | Adverse Drug Event | Drug ToxicityItaly
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Swiss Group for Clinical Cancer ResearchTerminatedAdenocarcinoma | Breast CancerSwitzerland
-
Eisai Inc.Completed
-
Eisai Inc.Children's Oncology GroupCompleted
-
Chang Gung Memorial HospitalEisai Co., Ltd.; Kaohsiung Breast Cancer Prevention and Education Society (KBCPES)UnknownAdvanced Breast Cancer | Metastatic Breast CancerTaiwan
-
Eisai Co., Ltd.Completed
-
Eisai Inc.Completed
-
Eisai Inc.CompletedLocally Recurrent | Metastatic Breast Cancer ( HER2 Negative)United States
-
Dana-Farber Cancer InstituteGenentech, Inc.; Eisai Inc.TerminatedMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Eisai Co., Ltd.CompletedInoperable or Recurrent Breast CancerJapan
-
MedSIRTerminated
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
Italian Sarcoma GroupEisai Inc.Recruiting
-
Eisai Inc.CompletedBreast CancerUnited States
-
Eisai Inc.Completed
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityActive, not recruiting
-
Institut Paoli-CalmettesEisai Inc.WithdrawnMetastatic Breast CancerFrance
-
University of OklahomaTerminatedLymphoma | Solid Tumors | Pediatric CancerUnited States
-
Vector OncologyEisai Inc.TerminatedHER-2 Positive Breast CancerUnited States